ProfileGDS4718 / 219363_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 81% 88% 77% 83% 93% 95% 81% 74% 82% 83% 78% 93% 97% 94% 84% 83% 95% 93% 94% 79% 82% 80% 82% 82% 93% 81% 92% 80% 92% 89% 91% 73% 74% 94% 88% 96% 83% 81% 88% 83% 94% 89% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2088883
GSM549102patient 115, normal, homogenized [OPG study]7.8558281
GSM549104patient 119, normal, homogenized [OPG study]8.9594888
GSM549108patient 138, normal, homogenized [OPG study]7.4194177
GSM549119patient 077, normal, homogenized [OPG study]8.1426783
GSM549133patient 032, cancer, homogenized [OPG study]9.8668793
GSM549139patient 042, cancer, homogenized [OPG study]10.288395
GSM549099patient 107, normal, homogenized [OPG study]7.923281
GSM549109patient 139, normal, homogenized [OPG study]7.1654974
GSM549110patient 046, normal, homogenized [OPG study]8.0543782
GSM549114patient 063, normal, homogenized [OPG study]8.3666783
GSM549122patient 082, normal, homogenized [OPG study]7.6653678
GSM549134patient 033, cancer, homogenized [OPG study]9.6536193
GSM549136patient 036, cancer, homogenized [OPG study]10.73297
GSM549140patient 044, cancer, homogenized [OPG study]9.8789994
GSM549111patient 047, normal, homogenized [OPG study]8.4736484
GSM549113patient 057, normal, homogenized [OPG study]8.3184883
GSM549132patient 031, cancer, homogenized [OPG study]10.027495
GSM549137patient 038, cancer, homogenized [OPG study]9.6324793
GSM549142patient 047, cancer, homogenized [OPG study]9.3662294
GSM549100patient 110, normal, homogenized [OPG study]7.696379
GSM549107patient 135, normal, homogenized [OPG study]8.1009182
GSM549115patient 068, normal, homogenized [OPG study]7.9885280
GSM549116patient 072, normal, homogenized [OPG study]8.1011782
GSM549120patient 078, normal, homogenized [OPG study]8.1404282
GSM549131patient 030, cancer, homogenized [OPG study]9.867293
GSM549118patient 074, normal, homogenized [OPG study]8.0424581
GSM549129patient 027, cancer, homogenized [OPG study]9.4355892
GSM549123patient 088, normal, homogenized [OPG study]7.8815580
GSM549124patient 006, cancer, homogenized [OPG study]9.4626892
GSM549126patient 015, cancer, homogenized [OPG study]8.9828289
GSM549128patient 025, cancer, homogenized [OPG study]9.3031791
GSM549103patient 117, normal, homogenized [OPG study]7.0579873
GSM549117patient 073, normal, homogenized [OPG study]7.1969774
GSM549138patient 041, cancer, homogenized [OPG study]9.9963294
GSM549141patient 045, cancer, homogenized [OPG study]9.0409988
GSM549130patient 028, cancer, homogenized [OPG study]10.297396
GSM549101patient 111, normal, homogenized [OPG study]8.1697183
GSM549105patient 128, normal, homogenized [OPG study]7.911781
GSM549106patient 134, normal, homogenized [OPG study]9.0612688
GSM549112patient 048, normal, homogenized [OPG study]8.2055383
GSM549125patient 011, cancer, homogenized [OPG study]9.9320994
GSM549127patient 024, cancer, homogenized [OPG study]9.0121389
GSM549135patient 035, cancer, homogenized [OPG study]10.21495